Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-15

Clinical Trial Update: ADRB3 Signaling Pathway in Human Adipose Tissue [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial from the University of California, San Diego is investigating ADRB3 signaling in human adipose tissue for obesity and prediabetes; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Diego | Conditions: Obesity, Prediabetes | Phase 1 | Status: ACTIVE_NOT_RECRUITING